Financing type:  underwritten prospectus offering

Gross proceeds:  $29.9-million

Offering:  11.5 million listed shares with 11.5 million warrants

Offering price:  $2.60 per listed share

Warrant exercise terms:  one-half of one six-month Class A common share purchase warrant (each whole six-month common share purchase warrant, a Series A warrant) and one-half of one 24-month Class A common share purchase warrant (each whole 24-month common share purchase warrant, a Series B warrant) (Each Series A warrant entitles the holder thereof to acquire one common share at an exercise price of $3.25 per Class A common share until May 18, 2026, and each Series B warrant entitles the holder thereof to acquire one Class A common share at an exercise price of $3.90 per Class A common share until Nov. 18, 2027.

Disclosure:  Refer to the prospectus dated Nov. 12, 2025, and company's news releases dated Nov. 10, 2025, and Nov. 18, 2025.